Aurilene G. Cajado

SN-38, the active metabolite of irinotecan, inhibits the acute inflammatory response by targeting toll-like receptor 4

F. Cunha, T. Cunha, A. Figueira, 2019, Cancer Chemotherapy and Pharmacology.

TLR4 deficiency upregulates TLR9 expression and enhances irinotecan‐related intestinal mucositis and late‐onset diarrhoea

F. Cunha, J. Pereira, R. Sant'ana, 2021, British journal of pharmacology.

Time-dependent modulation of AMPA receptor phosphorylation and mRNA expression of NMDA receptors and glial glutamate transporters in the rat hippocampus and cerebral cortex in a pilocarpine model of epilepsy

J. Nunes, R. Walz, R. Leal, 2013, Experimental Brain Research.